Showing 381-390 of 21407 results for "".
- ‘Sweat, Spike, Solve’: Research Suggests a New Strategy for People with Type 1 Diabetes to Lower Blood Sugar After Exercisehttps://reachmd.com/news/sweat-spike-solve-research-suggests-a-new-strategy-for-people-with-type-1-diabetes-to-lower-blood-sugar-after-exercise/2468400/Adults with Type 1 diabetes should perform aerobic cooldowns to manage high blood sugar after intense exercise where glucose levels might rise, according to current guidelines for managing the disease. However, this recommendation has never been empirica
- Tirzepatide for Type 2 Diabetes Associated with Lower Risks for Mortality, Adverse Heart, Kidney Eventshttps://reachmd.com/news/tirzepatide-for-type-2-diabetes-associated-with-lower-risks-for-mortality-adverse-heart-kidney-events/2467776/by Elana Gotkine For patients with type 2 diabetes, treatment with tirzepatide (a dual glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide receptor agonist) is associated with lower risks for all-cause mortality and adverse cardiovascular and kidney even
- Analysis Reveals the Global Burden of Type 1 Diabetes in Adults Aged 65 Years & Olderhttps://reachmd.com/news/analysis-reveals-the-global-burden-of-type-1-diabetes-in-adults-aged-65-years-older/2467078/The number of people aged 65 and older with type 1 diabetes increased from 1.3 million in 1990 to 3.7 million in 2019, while death rates fell 25% from 4.7 per 100,000 population in 1990 to 3.5 in 2019, finds an analysis of data from over 200 count
- Urolithin C alleviates Pancreatic β-Cell Dysfunction in Type 1 Diabetes by Activating Nrf2 Signalinghttps://reachmd.com/news/urolithin-c-alleviates-pancreatic-cell-dysfunction-in-type-1-diabetes-by-activating-nrf2-signaling/2457377/Type 1 diabetes (T1D) is an autoimmune disorder that destroys insulin-generating pancreatic β-cells. Preserving pancreatic β-cell function is important for treating T1D. Our study aims to explore the mechanism underlying urolithin C (UC)-mediated regulation of β-cell function.
- 13 New Biomarkers Could Help Better Predict Heart Disease Risk in People with Type 2 Diabeteshttps://reachmd.com/news/13-new-biomarkers-could-help-better-predict-heart-disease-risk-in-people-with-type-2-diabetes/2456995/An international academic consortium has identified 13 biomarkers that significantly improve the ability to accurately predict cardiovascular disease risk in people with type 2 diabetes. The analysis, conducted by 23 experts from 11 countries, was led by The Johns Hopkins University in the United
- In Patients with NAFLD, Type 2 Diabetes Significantly Ups Risk for Hepatic Decompensation, Hepatocellular Carcinomahttps://reachmd.com/news/in-patients-with-nafld-type-2-diabetes-significantly-ups-risk-for-hepatic-decompensation-hepatocellular-carcinoma/2451795/In individuals with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D), the risk of hepatic decompensation and hepatocellular carcinoma (HCC) at 5 years was more than 3-fold greater than among those without T2D, according to new data from an int
- APS Screening in Adults with Type 1 Diabetes Often Missedhttps://reachmd.com/news/aps-screening-in-adults-with-type-1-diabetes-often-missed/2488386/Key Takeaways At a tertiary diabetes center in Trieste, Italy, 31% of adults with T1DM met clinical APS criteria, but only 8.6% had APS formally documented in the medical record. Broader screening found previously unknown autoantibody positivity in 39% of tested pati
- Exercise: A Vital Tool for Mitigating Diabetes Risk in Greenlandhttps://reachmd.com/news/exercise-a-vital-tool-for-mitigating-diabetes-risk-in-greenland/2470949/What's New New research identifies that exercise can improve insulin sensitivity in the muscles of Greenlandic Inuit individuals carrying a genetic variant that predisposes them to type 2 diabetes. Significance This discovery is significant because i
- Incretin Therapies in Type 1 Diabetes: Reappraisal and Geriatric Considerationshttps://reachmd.com/news/incretin-therapies-in-type-1-diabetes-reappraisal-and-geriatric-considerations/2485909/A narrative review in Diabetology synthesizes experimental, clinical trial, and real-world evidence on incretin hormones (GLP-1 and GIP) and incre
- Advancing Maternal Care: Automated Insulin Systems in Type 1 Diabeteshttps://reachmd.com/news/advancing-maternal-care-automated-insulin-systems-in-type-1-diabetes/2484481/Automated closed-loop insulin delivery increased time in pregnancy glucose targets by roughly three hours per day in a randomized multicenter trial